Telmistrum CH 80/12.5

Telmistrum CH 80/12.5 is a prescription medicine that combines Telmisartan IP 80 mg and Chlorthalidone IP 12.5 mg in a single enteric-coated delayed-release tablet. This fixed-dose combination is prescribed by healthcare professionals for the management of hypertension (high blood pressure) in patients who require dual-drug therapy to achieve blood pressure control. a powerful prescription combination medication used to treat hypertension (high blood pressure)

Telmisartan belongs to the class of angiotensin II receptor blockers (ARBs), while Chlorthalidone is a thiazide-like diuretic. Together, these medicines work through complementary mechanisms to help reduce blood pressure. Effective blood pressure management may lower the risk of cardiovascular complications such as stroke, heart attack, and kidney damage when used as part of a physician-directed treatment plan.

How Telmisartan IP 80 mg + Chlorthalidone IP 12.5 mg Works

This fixed-dose combination contains two antihypertensive agents with different mechanisms of action.

Telmisartan

Telmisartan selectively blocks angiotensin II type-1 (AT1) receptors. This action relaxes blood vessels, reduces vascular resistance, and lowers blood pressure.

Chlorthalidone

Chlorthalidone is a thiazide-like diuretic that promotes the excretion of sodium and water through the kidneys, reducing circulating blood volume and contributing to blood pressure reduction.

Together, these mechanisms provide complementary blood pressure control in patients requiring combination therapy.

Therapeutic Indications

Telmisartan IP 80 mg + Chlorthalidone IP 12.5 mg tablets may be prescribed for:

• Management of essential hypertension
• Patients whose blood pressure is not adequately controlled with a single antihypertensive agent
• Long-term blood pressure management under physician supervision
• Reduction of cardiovascular risk through appropriate blood pressure control as part of comprehensive treatment

Treatment decisions should always be individualized by a qualified healthcare professional.

Dosage and Administration

• Use only as directed by a registered medical practitioner.
• Swallow the tablet whole with water.
• Take the medicine at the same time each day unless instructed otherwise.
• Do not change the dose or discontinue therapy without consulting the prescribing physician.
• Missed doses should be managed according to medical advice.

The appropriate dosage depends on the patient's clinical condition, blood pressure response, kidney function, and overall treatment plan.

Contraindications

This medicine should not be used in patients with:

• Hypersensitivity to Telmisartan, Chlorthalidone, or any component of the formulation
• Pregnancy (particularly the second and third trimesters)
• Severe hepatic impairment where contraindicated
• Anuria
• Certain severe electrolyte disturbances, as determined by the treating physician

Clinical judgment is required before initiating therapy.

Warnings and Precautions

Before prescribing this medicine, healthcare professionals should consider:

• Renal function
• Hepatic impairment
• Electrolyte imbalance
• Volume depletion
• Diabetes mellitus
• Hyperuricemia or gout
• Elderly patients
• Risk of hypotension
• Monitoring of serum potassium, sodium, and renal parameters where clinically appropriate

Regular follow-up may be required to assess treatment response and safety.

Possible Side Effects

Like all medicines, this combination may cause adverse effects, although not everyone experiences them.

Commonly reported adverse effects may include:

• Dizziness
• Headache
• Fatigue
• Increased urination
• Electrolyte imbalance
• Low blood pressure
• Elevated uric acid
• Muscle cramps

Patients should seek medical advice if they experience persistent or severe symptoms.

Drug Interactions

Healthcare professionals should review concomitant medications before prescribing.

Potential interactions may occur with:

• Other antihypertensive medicines
• Lithium
• NSAIDs
• Potassium supplements
• Potassium-sparing diuretics
• Digoxin
• Corticosteroids
• Antidiabetic medicines

Medication review is recommended before starting therapy.

Use During Pregnancy and Breastfeeding

This medicine should be used only according to physician advice.

• Use during pregnancy is generally contraindicated, particularly after the first trimester.
• Breastfeeding recommendations should be based on individual clinical assessment.

Patients planning pregnancy should consult their healthcare provider.

Storage Instructions

• Store in a cool and dry place.
• Protect from moisture and direct sunlight.
• Keep out of reach of children.
• Do not use after the expiry date.

Frequently Asked Questions 

1. What is Telmisartan IP 80 mg + Chlorthalidone IP 12.5 mg used for?

It is prescribed for the treatment of hypertension (high blood pressure) in patients who require combination antihypertensive therapy.

2. Is Telmisartan IP 80 mg + Chlorthalidone IP 12.5 mg an antibiotic?

No. It is an antihypertensive medicine and not an antibiotic.

3. Can this medicine be taken every day?

It should be taken exactly as prescribed by a registered medical practitioner.

4. How does this combination lower blood pressure?

Telmisartan relaxes blood vessels, while Chlorthalidone helps remove excess sodium and water from the body.

5. Can this medicine cure high blood pressure?

No. It helps control blood pressure but does not cure hypertension.

6. Should I stop taking the medicine if my blood pressure becomes normal?

No. Continue treatment only as advised by your healthcare provider.

7. Can diabetic patients take this medicine?

Some patients with diabetes may be prescribed this medicine, but treatment should be individualized by the prescribing physician.

8. Is regular blood pressure monitoring necessary?

Yes. Regular monitoring helps assess treatment response and supports appropriate medical management.

9. Can this medicine affect kidney function?

Kidney function should be monitored where clinically appropriate, especially in patients with pre-existing kidney disease or other risk factors.

10. What are the common side effects?

Possible side effects include dizziness, headache, fatigue, increased urination, and electrolyte imbalance. Patients should consult their healthcare provider if symptoms are severe or persistent.

11. Can this medicine be taken with other blood pressure medicines?

Only if specifically prescribed by a healthcare professional.

12. Is this medicine safe during pregnancy?

It is generally contraindicated during pregnancy, particularly after the first trimester. Patients should consult their physician immediately if pregnancy occurs during treatment.

Product Information

Brand Name: Telmistrum CH 80/12.5

Generic Composition:

• Telmisartan IP 80 mg
• Chlorthalidone IP 12.5 mg

Formulation: Enteric-coated delayed-release tablet

Pack Size: Strip of 10 tablets

Marketed By: Steris Healthcare Pvt. Ltd.

Quality Standard: WHO-GMP Certified

Prescription Status: Valid Prescription Required